Google Scholar | Citations: 16429| h-index: 32 | i10-index: 482
Modification of leukocyte parameters induced by inflammatory processes resulting from increased insulin resistance
PDF (Portuguese (Brazil))

Keywords

Insulin resistance
Metabolic syndrome
Inflammation

How to Cite

Modification of leukocyte parameters induced by inflammatory processes resulting from increased insulin resistance. (2025). Electronic Journal Collection Health, 25(9), e21304. https://doi.org/10.25248/reas.e21304.2025

Copyright © | All rights reserved.

The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.

Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.

Total reproduction
It is expressly prohibited and must be authorized by the journal.

Abstract

Objective: To investigate the possible correlation between increased insulin resistance, calculated using the HOMA-IR index, and changes in inflammatory response parameters, with a focus on total neutrophils, total lymphocytes, and the neutrophil-to-lymphocyte ratio (NLR), in patients affiliated with the Municipal Health Department of a metropolitan region in Curitiba. Methods: This was an analytical, cross-sectional, and retrospective study involving 186 individuals of both sexes. Laboratory tests (complete blood count, insulin, and glucose) were performed. Neutrophils, lymphocytes, NLR, and HOMA-IR were analyzed. Results: Patients with HOMA-IR ≥ 2.71 were classified as having increased insulin resistance. The correlation between HOMA-IR and leukocyte parameters was assessed using descriptive analysis and Spearman’s correlation. The results indicated a weak but positive correlation between HOMA-IR and total neutrophils (ρ=0.352, p<0.001) and total lymphocytes (ρ=0.300, p<0.001). However, no significant correlation was found for the neutrophil-to-lymphocyte ratio (ρ=0.123, p=0.093). Conclusion: Increased insulin resistance is associated with elevated total neutrophil and lymphocyte counts but does not significantly affect the neutrophil-to-lymphocyte ratio. Study limitations include the lack of assessment of comorbidities, anthropometric data, and additional inflammatory markers.

PDF (Portuguese (Brazil))

References

BAGYURA Z, et al. Neutrophil-to-lymphocyte ratio is an independent risk factor for coronary artery disease in central obesity. International Journal of Molecular Sciences, 2023; 24: 7397.

BALTA S, et al. The relation between atherosclerosis and the neutrophil-lymphocyte ratio. Clinical and Applied Thrombosis/Hemostasis, 2016; 22: 405-411.

BARAKAT B, ALMEIDA MEF. Biochemical and immunological changes in obesity. Archives of Biochemistry and Biophysics, 2021; 708: 108951.

CHRISTOU KA, et al. Metabolically healthy obesity is characterized by a proinflammatory phenotype of circulating. Metabolic Syndrome and Related Disorders, 2019; XX: 1-7.

ELLINGER VCM, et al. Relation between insulin resistance and hematological parameters in a Brazilian sample. Arquivos Brasileiros de Endocrinologia e Metabologia, 2006; 50: 114–117.

ENGİN A. The definition and prevalence of obesity and metabolic syndrome. Advances in Experimental Medicine and Biology, 2017; 960: 1-17.

GRANDL G, WOLFRUM C. Hemostasis, endothelial stress, inflammation, and the metabolic syndrome. Seminars in Immunopathology, 2018; 40: 215-224.

HASHEMI MP, et al. Is the neutrophil-to-lymphocyte ratio an exceptional indicator for metabolic syndrome disease and outcomes? Endocrine Practice, 2022; 28:342-348.

LEHRSKOV LL, CHRISTENSEN RH. The role of interleukin-6 in glucose homeostasis and lipid metabolism. Seminars in immunopathology. 2019; 41:491-499.

MARRA A, et al. The neutrophil to lymphocyte ratio (NLR) positively correlates with the presence and severity of metabolic syndrome in obese adults, but not in obese children/adolescents. BMC Endocrine Disorders, 2023; 23: 121.

PURDY JC, SHATZEL JJ. The hematologic consequences of obesity. European Journal of Haematology, 2021; 106: 306–319.

QIU Z, et al. Predictive role of neutrophil-to-lymphocyte ratio in metabolic syndrome: meta-analysis of 70,937 individuals. BMC Endocrine Disorders, 2024; 24: 155.

RAMKHELAWON B, et al. Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity. Nature medicine, 2014; 20:377-84.

ROHM TV, et al. Inflammation in obesity, diabetes, and related disorders. Immunity, 2022: 55: 31-55.

RUBINO F, et al. Definition and diagnostic criteria of clinical obesity. The Lancet Diabetes & Endocrinology, 2025; 13: 221-262.

SILVEIRA ROSSI JL, et al. Metabolic syndrome and cardiovascular diseases: going beyond traditional risk factors. Diabetes Metabolism Research and Reviews, 2022; 38: e3502.

SOCIEDADE BRASILEIRA DE DIABETES – SBD. Diretrizes da Sociedade Brasileira de Diabetes 2019-2020. São Paulo: Câmara Brasileira do Livro, 2019.

XU L, et al. Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease. Biomolecules, 2015; 5:1563-79.

ZAHOREC R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratislava Medical Journal, 2021; 122: 474–488.

ZHANG SS, et al. Leukocyte related parameters in older adults with metabolically healthy and unhealthy overweight or obesity. Scientific Reports, 2021; 11: 4652.